INDEPENDENCE CONTRACT DRILLI (ICD) Stock Fundamental Analysis
NYSE:ICD - New York Stock Exchange, Inc. - US4534156066 - Common Stock - Currency: USD
Taking everything into account, ICD scores 1 out of 10 in our fundamental rating. ICD was compared to 59 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of ICD have multiple concerns. ICD is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ICD has reported negative net income.
ICD had a positive operating cash flow in the past year.
ICD had negative earnings in each of the past 5 years.
Of the past 5 years ICD 4 years had a positive operating cash flow.
1.2 Ratios
ICD has a worse Return On Assets (-15.80%) than 92.06% of its industry peers.
ICD has a Return On Equity of -37.58%. This is amonst the worse of the industry: ICD underperforms 87.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.8% | ||
| ROE | -37.58% | ||
| ROIC | N/A |
ROA(3y)-13.85%
ROA(5y)-15.34%
ROE(3y)-28.45%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ICD's Operating Margin has improved in the last couple of years.
ICD has a Gross Margin of 32.59%. This is in the better half of the industry: ICD outperforms 65.08% of its industry peers.
ICD's Gross Margin has improved in the last couple of years.
ICD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.59% |
OM growth 3YN/A
OM growth 5Y66.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.54%
GM growth 5Y2.72%
2. Health
2.1 Basic Checks
ICD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ICD has been increased compared to 5 years ago.
ICD has a worse debt/assets ratio than last year.
2.2 Solvency
ICD has an Altman-Z score of -1.26. This is a bad value and indicates that ICD is not financially healthy and even has some risk of bankruptcy.
ICD's Altman-Z score of -1.26 is on the low side compared to the rest of the industry. ICD is outperformed by 88.89% of its industry peers.
The Debt to FCF ratio of ICD is 10.37, which is on the high side as it means it would take ICD, 10.37 years of fcf income to pay off all of its debts.
ICD has a Debt to FCF ratio of 10.37. This is comparable to the rest of the industry: ICD outperforms 46.03% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that ICD has dependencies on debt financing.
ICD's Debt to Equity ratio of 1.08 is on the low side compared to the rest of the industry. ICD is outperformed by 79.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | 10.37 | ||
| Altman-Z | -1.26 |
ROIC/WACCN/A
WACC2.02%
2.3 Liquidity
ICD has a Current Ratio of 1.33. This is a normal value and indicates that ICD is financially healthy and should not expect problems in meeting its short term obligations.
ICD has a Current ratio of 1.33. This is in the lower half of the industry: ICD underperforms 79.37% of its industry peers.
A Quick Ratio of 1.28 indicates that ICD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.28, ICD is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
ICD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -662.07%.
Looking at the last year, ICD shows a very negative growth in Revenue. The Revenue has decreased by -21.60% in the last year.
Measured over the past years, ICD shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)-662.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-942.86%
Revenue 1Y (TTM)-21.6%
Revenue growth 3Y36.07%
Revenue growth 5Y8.06%
Sales Q2Q%-23.12%
3.2 Future
ICD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -46.50% yearly.
The Revenue is expected to decrease by -8.70% on average over the next years.
EPS Next Y-146.84%
EPS Next 2Y-46.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.87%
Revenue Next 2Y-8.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ICD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICD is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ICD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.54 | ||
| EV/EBITDA | 4.69 |
4.3 Compensation for Growth
A cheap valuation may be justified as ICD's earnings are expected to decrease with -46.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.5%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ICD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.5858
-0.06 (-9.88%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.01%
Inst Owner Change0%
Ins Owners75.82%
Ins Owner Change-0.97%
Market Cap8.92M
Analysts80
Price Target3.57 (509.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.38%
Min EPS beat(2)-50.58%
Max EPS beat(2)-2.18%
EPS beat(4)0
Avg EPS beat(4)-48.02%
Min EPS beat(4)-115.7%
Max EPS beat(4)-2.18%
EPS beat(8)4
Avg EPS beat(8)27.37%
EPS beat(12)5
Avg EPS beat(12)-68.42%
EPS beat(16)9
Avg EPS beat(16)-49.21%
Revenue beat(2)2
Avg Revenue beat(2)6.69%
Min Revenue beat(2)2.48%
Max Revenue beat(2)10.9%
Revenue beat(4)3
Avg Revenue beat(4)3.1%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)10.9%
Revenue beat(8)6
Avg Revenue beat(8)2.51%
Revenue beat(12)8
Avg Revenue beat(12)2.8%
Revenue beat(16)9
Avg Revenue beat(16)0.49%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-48.55%
EPS NQ rev (3m)-25.02%
EPS NY rev (1m)-36.74%
EPS NY rev (3m)-10.78%
Revenue NQ rev (1m)-14.34%
Revenue NQ rev (3m)-18.05%
Revenue NY rev (1m)-3.15%
Revenue NY rev (3m)-5.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.05 | ||
| P/FCF | 0.54 | ||
| P/OCF | 0.21 | ||
| P/B | 0.06 | ||
| P/tB | 0.06 | ||
| EV/EBITDA | 4.69 |
EPS(TTM)-2.21
EYN/A
EPS(NY)-1.95
Fwd EYN/A
FCF(TTM)1.09
FCFY186.61%
OCF(TTM)2.86
OCFY487.46%
SpS11.83
BVpS10.37
TBVpS10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.8% | ||
| ROE | -37.58% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.59% | ||
| FCFM | 9.24% |
ROA(3y)-13.85%
ROA(5y)-15.34%
ROE(3y)-28.45%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y66.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.54%
GM growth 5Y2.72%
F-Score3
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | 10.37 | ||
| Debt/EBITDA | 4.57 | ||
| Cap/Depr | 58.68% | ||
| Cap/Sales | 14.9% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 116% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z | -1.26 |
F-Score3
WACC2.02%
ROIC/WACCN/A
Cap/Depr(3y)80.67%
Cap/Depr(5y)71.77%
Cap/Sales(3y)20.36%
Cap/Sales(5y)19.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-662.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-942.86%
EPS Next Y-146.84%
EPS Next 2Y-46.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.6%
Revenue growth 3Y36.07%
Revenue growth 5Y8.06%
Sales Q2Q%-23.12%
Revenue Next Year-20.87%
Revenue Next 2Y-8.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-138.99%
EBIT growth 3YN/A
EBIT growth 5Y79.64%
EBIT Next Year42.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y162.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2030.36%
OCF growth 3Y494.79%
OCF growth 5Y30.47%